USWM CT, LLC

1 FDA products 1 active ingredients CELLULAR THERAPY

USWM CT, LLC is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly cellular therapy products.

About USWM CT, LLC

USWM CT, LLC is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by AFAMITRESGENE AUTOLEUCEL. Most of these labels are cellular therapy products. Labelling across this portfolio most often references: treatment adults, pediatric patients, years age, unresectable metastatic, synovial sarcoma, received prior, hla-a positive, tumor expresses. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
AFAMITRESGENE AUTOLEUCEL 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — INTRAVENOUS 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from USWM CT, LLC

Brand nameGenericTypeRoute
TECELRA AFAMITRESGENE AUTOLEUCEL CELLULAR THERAPY INTRAVENOUS

Frequently asked questions

How many FDA drug products does USWM CT, LLC make?
1 FDA drug label records name USWM CT, LLC as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does USWM CT, LLC produce?
The most frequent active ingredients in this portfolio are AFAMITRESGENE AUTOLEUCEL.

Are USWM CT, LLC products prescription or over-the-counter?
The largest share of this company’s labels are cellular therapy products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.